Mongolia has the world’s highest rate of liver cancer mortality; nearly eight times the global average. The prevalence of chronic viral hepatitis B, C, and D is at endemic level, and constitutes the main reason cause of Mongolia’s world-leading liver cancer mortality rate. To tackle this deadly crisis, the Onom Foundation, Patient and Civil Society Council, Mongolian Gastroenterology Association, and Mongolian Society of Hepatology launched the Hepatitis Prevention, Control, and Elimination (HPCE).
The foundation is collaborating with the Mongolian society of Hepatology, Mongolian Gastroenterology Association, the Onom Foundation and EASL to hold first European Union – Mongolia Hepatology Conference, which will take place on August 17 – 19, 2017 in Ulaanbaatar, Mongolia. The conference will bring together clinicians, scientists, and specialists to advance the HPCE Program in Mongolia, and lay the ground work for other countries to follow.
Dr Naranbaatar Dashdorj, Co-Founder and Chair of the Board of the Onom Foundation states: “Mongolia, a champion country in hepatitis elimination, is honored to cooperate with the European Association for the Study of the Liver and EASL International Liver Foundation in achieving the MISSION 2020 of the HPCE Program. Our cooperation not only helps Mongolia to reach its hepatitis elimination goals but also demonstrates to the world that together we can eliminate viral hepatitis as a public health threat by 2030, a goal that was unanimously approved by all 190 member states of the World Health Organization in May of 2016.”